Trials / Unknown
UnknownNCT03874247
Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury
A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 94 (estimated)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, double-blind, placebo-controlled, parallel, multi-center phase III clinical trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pelubiprofen 45mg | bid for 3 days after meal |
| DRUG | pelubiprofen placebo | bid for 3 days after meal |
Timeline
- Start date
- 2019-02-25
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2019-03-14
- Last updated
- 2019-03-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03874247. Inclusion in this directory is not an endorsement.